Literature DB >> 33420658

Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy.

Wen-Jun Zhang1.   

Abstract

The development of tumors is a complex pathological process involving multiple factors, multiple steps, and multiple genes. Their prevention and treatment have always been a difficult problem at present. A large number of studies have proved that the tumor microenvironment plays an important role in the progression of tumors. The tumor microenvironment is the place where tumor cells depend for survival, and it plays an important role in regulating the growth, proliferation, apoptosis, migration, and invasion of tumor cells. P2X purinergic receptors, which depend on the ATP ion channel, can be activated by ATP in the tumor microenvironment, and by mediating tumor cells and related cells (such as immune cells) in the tumor microenvironment. They play an important regulatory role on the effects of the skeleton, membrane fluidity, and intracellular molecular metabolism of tumor cells. Therefore, here, we outlined the biological characteristics of P2X purinergic receptors, described the effect of tumor microenvironment on tumor progression, and discussed the effect of ATP on tumor. Moreover, we explored the role of P2X purinergic receptors in the development of tumors and anti-tumor therapy. These data indicate that P2X purinergic receptors may be used as another potential pharmacological target for tumor prevention and treatment.

Entities:  

Keywords:  ATP; P2X purinergic receptors; Tumor microenvironment; Tumors

Mesh:

Substances:

Year:  2021        PMID: 33420658      PMCID: PMC7954979          DOI: 10.1007/s11302-020-09761-8

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  157 in total

Review 1.  Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.

Authors:  Shu Yang; Huile Gao
Journal:  Pharmacol Res       Date:  2017-05-10       Impact factor: 7.658

Review 2.  Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.

Authors:  Wen-Jun Zhang; Ce-Gui Hu; Zheng-Ming Zhu; Hong-Liang Luo
Journal:  Biomed Pharmacother       Date:  2020-01-28       Impact factor: 6.529

Review 3.  The role and pharmacological properties of the P2X7 receptor in neuropathic pain.

Authors:  Wen-Jun Zhang; Zheng-Ming Zhu; Zeng-Xu Liu
Journal:  Brain Res Bull       Date:  2019-11-25       Impact factor: 4.077

4.  Luciferase-assisted detection of extracellular ATP and ATP metabolites during immunogenic death of cancer cells.

Authors:  George R Dubyak
Journal:  Methods Enzymol       Date:  2019-10-29       Impact factor: 1.600

Review 5.  Acidosis and proteolysis in the tumor microenvironment.

Authors:  Kyungmin Ji; Linda Mayernik; Kamiar Moin; Bonnie F Sloane
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

Review 6.  Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.

Authors:  Laetitia Aymeric; Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Isabelle Martins; Guido Kroemer; Mark J Smyth; Laurence Zitvogel
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

Review 7.  Extracellular ATP and P2 purinergic signalling in the tumour microenvironment.

Authors:  Francesco Di Virgilio; Alba Clara Sarti; Simonetta Falzoni; Elena De Marchi; Elena Adinolfi
Journal:  Nat Rev Cancer       Date:  2018-10       Impact factor: 60.716

Review 8.  Adenosine Metabolism: Emerging Concepts for Cancer Therapy.

Authors:  Detlev Boison; Gennady G Yegutkin
Journal:  Cancer Cell       Date:  2019-12-09       Impact factor: 31.743

Review 9.  The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.

Authors:  Geoffrey Burnstock; Gillian E Knight
Journal:  Purinergic Signal       Date:  2017-11-21       Impact factor: 3.765

Review 10.  Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment.

Authors:  Xinyu Tian; Han Shen; Zhiyang Li; Tingting Wang; Shengjun Wang
Journal:  J Hematol Oncol       Date:  2019-08-22       Impact factor: 17.388

View more
  1 in total

Review 1.  Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis.

Authors:  Xian-Ming Wu; Ning Zhang; Jiang-Shan Li; Zhi-Hong Yang; Xiao-Lou Huang; Xiao-Fang Yang
Journal:  Purinergic Signal       Date:  2022-01-03       Impact factor: 3.765

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.